On Tuesday, 12 October 2021, Bharat Biotech's COVID-19 vaccine (Covaxin) for children between the ages of 2 and 18, has been granted emergency use approval (EAU) by the Subject Expert Committee (SEC).
However, the Drugs Controller General of India (DCGI) is yet to approve the submitted data.
Earlier, Bharat Biotech had submitted the data to the Central Drugs Standard Control Organisation (CDSCO) for its verification which has now been thoroughly reviewed and positive recommendations have been provided by them as well.
0 Comments